PortViewPortView
LeMaitre Vascular logo

LeMaitre Vascular (LMAT) Stock Analysis

NASDAQHealthcareMedical - Instruments & Supplies

$81.30+0.27%
1-year price historyRange $78.97 – $117.39
52-week range$81.30
$78.27$118.01

What LeMaitre Vascular does

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.

Key metrics

Market cap
$1.86B
P/E (TTM)
29.89
EPS (TTM)
$2.72
Beta
0.52
Dividend yield
1.17%
Revenue / share
$11.48
50-day avg
$92.44
200-day avg
$95.08
52-week high
$118.01
52-week low
$78.27
CEO
George W. LeMaitre

ETFs linked to LMAT

Broad-market and Healthcare sector ETFs an investor holding LeMaitre Vascular is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how LMAT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze LMAT in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for LeMaitre Vascular?
LeMaitre Vascular trades under the ticker LMAT on NASDAQ.
Which exchange is LMAT listed on?
LMAT is listed on NASDAQ.
What sector does LeMaitre Vascular operate in?
LeMaitre Vascular is classified in the Healthcare sector (Medical - Instruments & Supplies industry).
How can PortView help analyze LMAT in a portfolio?
PortView shows LMAT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.